Collegium Pharmaceutical Inc
F:354
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Collegium Pharmaceutical Inc
F:354
|
US |
|
C
|
CTT - Correios de Portugal SA
ELI:CTT
|
PT |
|
G
|
Global Bio-chem Technology Group Co Ltd
OTC:GBCMF
|
HK |
|
Stanley Electric Co Ltd
OTC:STAEF
|
JP |
|
T
|
Tecsys Inc
F:9T1
|
CA |
|
U
|
US Bancorp
BMV:USB
|
US |
|
H
|
Heidelberg Pharma AG
XHAM:HPHA
|
DE |
|
A
|
Analog Devices Inc
DUS:ANL
|
US |
|
J
|
Jabil Inc
XMUN:JBL
|
US |
|
E
|
East West Bancorp Inc
F:EW2
|
US |
|
S
|
Schneider Electric SE
DUS:SND
|
FR |
|
W
|
Wasko SA
F:8FT
|
PL |
|
New Amsterdam Invest NV
F:4C4
|
NL |
|
Riverstone Holdings Ltd
SGX:AP4
|
SG |
|
Pulmonx Corp
NASDAQ:LUNG
|
US |
|
Jack Henry & Associates Inc
LSE:0A6D
|
US |
|
AKB Primor'ye PAO
MOEX:PRMB
|
RU |
|
F
|
Fosun International Ltd
XMUN:FNI
|
HK |
|
T
|
Telefonica SA
F:TNE2
|
ES |
|
Holland Colours NV
AEX:HOLCO
|
NL |
|
P
|
Pearson PLC
F:PES
|
UK |
|
P
|
Pulmonx Corp
F:4NI
|
US |
|
T
|
Thermal Energy International Inc
F:EUW
|
CA |
Bankruptcy Probability
Collegium Pharmaceutical Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Collegium Pharmaceutical Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Collegium Pharmaceutical Inc
NASDAQ:COLL
|
709.8m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
622.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
355B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
338.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
224.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
184.1B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
317B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
160.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Collegium Pharmaceutical Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Collegium Pharmaceutical Inc has total debt of 1.2B USD. This includes both short-term (0 USD) and long-term (1.2B USD) debt.
You can find a full breakdown on its Balance Sheet.